Analyst Consensus ?
ConsensusBuy38 ratings
Bullish3079.0%
Neutral718.4%
Bearish12.6%
Citizens Financial Group, Inc. · CFG · FY2024 Q2 · Calendar Q3 2024
CFG: Fee growth and private banking support a maintained outlook
The supplied analysis supports a constructive but qualified view: fee growth, private-bank expansion and deposit-cost discipline strengthen the operating trajectory, while CRE exposure, funding costs and loan demand remain material tests.
Reported Before market openNYSEFinancial Services
$26.69B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.78
Consensus $0.79
EPS surprise
-1.3%
Reported versus consensus
Reported revenue
$3.16B
Consensus $1.95B
Revenue surprise
+62.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+3.3%
Event window
SPY move
-1.4%
Same window
Abnormal move
+4.7%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
-2.0%
Up to 20 sessions
CFGSPY benchmark
Ask FN2 about CFG FY2024 Q2
Transcript, numbers and history already loaded
Why did CFG rise 3.3% after missing EPS estimates in FY2024 Q2?What changed in CFG's guidance and outlook in FY2024 Q2?Give me the bull and bear case for CFG after FY2024 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, the focus shifted toward faster private-bank scaling, continued CRE run-off, broader fee momentum and execution of the TOP program, while the overall guidance stance remained maintained.
Guidance delta
Maintained; the supplied analysis says management remains upbeat on second-half loan growth despite macro uncertainty.
Key takeaways
- Fee revenue growth was led by capital markets, wealth and card activity.
- Private banking continued to scale and diversify the loan book.
- Deposit-cost management supported net interest income.
- Balance-sheet optimization remains a central part of the plan.
Management priorities
- Expand private banking offices and commercial-banking teams.
- Diversify fee revenue through wealth, card and capital-markets initiatives.
- Reduce CRE exposure and redeploy liquidity toward loan growth.
- Use data, analytics and generative-AI initiatives to improve efficiency.
Follow CFG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$63.36Current
$33Low
$63.67Average
$90High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 14, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 1, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 17, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 17, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 17, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 16, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 22, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 22, 2026 |
| Raymond James | Outperform | Strong Buy | Downgrade | Jan 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 17, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 18, 2024 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 23, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 20, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 12, 2022 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Argus | Buy | Hold | Upgrade | Jul 29, 2019 |
| Macquarie | Outperform | Neutral | Upgrade | Nov 27, 2018 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 22, 2018 |
| Bank of America | Buy | Underperform | Upgrade | Oct 22, 2018 |
| Sandler O'Neill | Buy | Hold | Upgrade | Apr 23, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Apr 21, 2017 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Nov 29, 2016 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Nov 15, 2016 |
| Wells Fargo | Outperform | Market Perform | Upgrade | May 13, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 26, 2015 |
| Evercore Partners | Buy | Buy | Maintain | Nov 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $63.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Dave Rochester | $78 | $63.3 | +23.1% | Oct 14, 2026 |
| Raymond James | Analyst unavailable | $77 | $64.09 | +21.5% | Oct 6, 2026 |
| UBS | Analyst unavailable | $77 | $64.33 | +21.5% | Oct 5, 2026 |
| Evercore ISI | John Pancari | $78 | $63.76 | +23.1% | Oct 1, 2026 |
| Morgan Stanley | Analyst unavailable | $89 | $64.93 | +40.5% | Sep 28, 2026 |
| Truist Financial | Brian Foran | $77 | $65.49 | +21.5% | Sep 23, 2026 |
| Morgan Stanley | Ryan Kenny | $90 | $70.78 | +42.0% | Sep 8, 2026 |
| Cantor Fitzgerald | Dave Rochester | $84 | $73.46 | +32.6% | Aug 19, 2026 |
| Argus Research | Kevin Heal | $80 | $72.57 | +26.3% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $80 | $71.5 | +26.3% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $85 | $74.4 | +34.2% | Jul 17, 2026 |
| Stephens | Matt Breese | $70 | $74.4 | +10.5% | Jul 17, 2026 |
| Robert W. Baird | Analyst unavailable | $75 | $74.4 | +18.4% | Jul 17, 2026 |
| Jefferies | Analyst unavailable | $90 | $74.1 | +42.0% | Jul 16, 2026 |
| Evercore ISI | John Pancari | $80 | $71.7 | +26.3% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $72 | $70.98 | +13.6% | Jul 6, 2026 |
| Truist Financial | Analyst unavailable | $72 | $68.99 | +13.6% | Jun 24, 2026 |
| Evercore ISI | Analyst unavailable | $75 | $66.47 | +18.4% | Apr 21, 2026 |
| D.A. Davidson | Analyst unavailable | $74 | $64.45 | +16.8% | Apr 20, 2026 |
| RBC Capital | Gerard Cassidy | $70 | $64.97 | +10.5% | Apr 17, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $58.31 | +2.6% | Mar 9, 2026 |
| Evercore ISI | John Pancari | $77 | $66.51 | +21.5% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $71 | $62.62 | +12.1% | Jan 26, 2026 |
| Argus Research | Kevin Heal | $72 | $63.64 | +13.6% | Jan 23, 2026 |
| New Street | Analyst unavailable | $73 | $65.43 | +15.2% | Jan 22, 2026 |
| RBC Capital | Analyst unavailable | $67 | $65.07 | +5.7% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $73 | $64.06 | +15.2% | Jan 22, 2026 |
| Jefferies | David Chiaverini | $80 | $64.06 | +26.3% | Jan 21, 2026 |
| Raymond James | David Long | $66 | $62.14 | +4.2% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $69 | $61.2 | +8.9% | Jan 6, 2026 |
| Goldman Sachs | Ryan Nash | $73 | $61.23 | +15.2% | Jan 6, 2026 |
| Barclays | Jason Goldberg | $77 | $59.39 | +21.5% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $63 | $59.59 | -0.6% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $60 | $58.46 | -5.3% | Dec 11, 2025 |
| Truist Financial | Analyst unavailable | $56 | $48.39 | -11.6% | Oct 17, 2025 |
| Stephens | Q3 EPS | $60 | $50.64 | -5.3% | Oct 16, 2025 |
| UBS | Analyst unavailable | $62 | $53.16 | -2.1% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $62 | $54 | -2.1% | Oct 7, 2025 |
| Truist Financial | Brian Foran | $58 | $52.98 | -8.5% | Oct 3, 2025 |
| Evercore ISI | Analyst unavailable | $61 | $53.65 | -3.7% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $71 | $53.38 | +12.1% | Sep 29, 2025 |
| Evercore ISI | Analyst unavailable | $57 | $52.27 | -10.0% | Sep 17, 2025 |
| Wells Fargo | Analyst unavailable | $57 | $47.03 | -10.0% | Jul 2, 2025 |
| Argus Research | Kevin Heal | $45 | $36.95 | -29.0% | Apr 24, 2025 |
| Truist Financial | Analyst unavailable | $51 | $41.19 | -19.5% | Mar 21, 2025 |
| Raymond James | David Long | $58 | $44.7 | -8.5% | Jan 21, 2025 |
| D.A. Davidson | Peter Winter | $48 | $42 | -24.2% | Oct 17, 2024 |
| RBC Capital | Gerard Cassidy | $45 | $42.41 | -29.0% | Oct 17, 2024 |
| Citigroup | Keith Horowitz | $50 | $42.41 | -21.1% | Oct 17, 2024 |
| Evercore ISI | John Pancari | $46 | $39.92 | -27.4% | Oct 2, 2024 |
| Morgan Stanley | Manan Gosalia | $50 | $39.2 | -21.1% | Aug 5, 2024 |
| Piper Sandler | Scott Siefers | $48 | $43.5 | -24.2% | Jul 26, 2024 |
| Morgan Stanley | Manan Gosalia | $41 | $40.92 | -35.3% | Jul 17, 2024 |
| Piper Sandler | Scott Siefers | $41 | $35.15 | -35.3% | Apr 26, 2024 |
| Wedbush | David Chiaverini | $35 | $33.05 | -44.8% | Apr 18, 2024 |
| UBS | Erika Najarian | $40 | $35.12 | -36.9% | Apr 4, 2024 |
| Morgan Stanley | Betsy Graseck | $33 | $26.96 | -47.9% | Aug 25, 2023 |
| Robert W. Baird | David George | $44 | $27.97 | -30.6% | May 23, 2023 |
| Barclays | Analyst unavailable | $57 | $39.37 | -10.0% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $47 | $38.64 | -25.8% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $53 | $41.7 | -16.4% | Dec 5, 2022 |
| Goldman Sachs | Analyst unavailable | $41 | $34.45 | -35.3% | Oct 3, 2022 |
| Deutsche Bank | Analyst unavailable | $50 | $39.12 | -21.1% | Sep 12, 2022 |
| Barclays | Jason Goldberg | $54 | $37.97 | -14.8% | Jul 31, 2022 |
| RBC Capital | Analyst unavailable | $55 | $36.27 | -13.2% | Jul 7, 2022 |
| Stephens | Analyst unavailable | $48 | $35.83 | -24.2% | Jun 13, 2022 |
| Goldman Sachs | Analyst unavailable | $49 | $40.87 | -22.7% | May 31, 2022 |
| Wolfe Research | Analyst unavailable | $33 | $39.6 | -47.9% | May 26, 2022 |
| Deutsche Bank | Matt O'Connor | $56 | $51.7 | -11.6% | Jan 28, 2022 |
| Credit Suisse | Susan Roth Katzke | $50 | $50.72 | -21.1% | Jan 24, 2022 |
| Citigroup | Jill Shea | $65 | $55.21 | +2.6% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $62 | $48.77 | -2.1% | Jan 3, 2022 |
| Bank of America Securities | Ebrahim Poonawala | $52 | $42.92 | -17.9% | Jul 21, 2021 |
| Evercore ISI | John Pancari | $50 | $48.68 | -21.1% | May 28, 2021 |
| Piper Sandler | Kevin Barker | $54 | $48.86 | -14.8% | May 27, 2021 |
| Compass Point | Dave Rochester | $55 | $48.42 | -13.2% | May 18, 2021 |
| Argus Research | Kevin Heal | $50 | $43.15 | -21.1% | Apr 19, 2021 |
Track every rating change on CFG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCitizens Financial Group, Inc. (CFG) functions as the holding company for Citizens Bank, National Association, a major financial institution offering a comprehensive suite of retail and commercial banking solutions across the United States. It serves a broad spectrum of clients, from individual consumers and small enterprises to large corporations and various institutions. Its business is segmented into two primary divisions: Consumer Banking and Commercial Banking. The Consumer Banking division delivers a robust array of products, encompassing deposit accounts, mortgage and home equity lending, credit cards, and business loans for smaller entities. It also provides wealth management, investment services, and specialized financing for areas like auto, education, and point-of-sale purchases, alongside digital deposit solutions. Clients engage with this segment through contact centers and its advanced online and mobile banking platforms.…
Historical context
All CFG earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee growth supports a steady Q3 outlook |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | -50.9% | — | Truist sharpens focus as Q3 EPS rises 12% |
| TRV The Travelers Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +24.2% | +1.5% | Travelers posts strong Q3, with investment income above $900 million |
Latest beats and misses
Who reports nextBeat on EPS
Get the CFG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-17T14:40:41.544694+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T14:40:41.541754+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.